EdgarLookup

CHEMUNG FINANCIAL CORP — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that CHEMUNG FINANCIAL CORP filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
0.6%
Return on Assets
Net income ÷ assets
9.64x
Debt-to-Equity
Total liabilities ÷ equity

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $15.10M Mar 13, 2026
FY2025 Dec 31, 2024 $23.67M Mar 13, 2026
FY2024 Dec 31, 2023 $25.00M Mar 14, 2025
FY2023 Dec 31, 2022 $28.78M Mar 13, 2024
FY2022 Dec 31, 2021 $26.43M Mar 22, 2023
FY2021 Dec 31, 2020 $19.26M Mar 23, 2022
FY2020 Dec 31, 2019 $15.61M Mar 24, 2021
FY2020 Dec 31, 2018 $19.63M Mar 24, 2021
FY2019 Dec 31, 2017 $7.43M Mar 12, 2020
FY2018 Dec 31, 2016 $10.03M Mar 13, 2019

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $45.50M Mar 13, 2026
FY2025 Dec 31, 2024 $29.82M Mar 13, 2026
FY2024 Dec 31, 2023 $30.88M Mar 14, 2025
FY2023 Dec 31, 2022 $35.05M Mar 13, 2024
FY2022 Dec 31, 2021 $35.46M Mar 22, 2023
FY2021 Dec 31, 2020 $28.66M Mar 23, 2022
FY2020 Dec 31, 2019 $26.41M Mar 24, 2021
FY2020 Dec 31, 2018 $27.77M Mar 24, 2021
FY2019 Dec 31, 2017 $23.65M Mar 12, 2020
FY2018 Dec 31, 2016 $22.14M Mar 13, 2019

Capital Expenditures (Capex)

Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $1.69M Mar 13, 2026
FY2025 Dec 31, 2024 $3.63M Mar 13, 2026
FY2024 Dec 31, 2023 $462.0K Mar 14, 2025
FY2023 Dec 31, 2022 $426.0K Mar 13, 2024
FY2022 Dec 31, 2021 $367.0K Mar 22, 2023
FY2021 Dec 31, 2020 $867.0K Mar 23, 2022
FY2020 Dec 31, 2019 $883.0K Mar 24, 2021
FY2020 Dec 31, 2018 $1.77M Mar 24, 2021
FY2019 Dec 31, 2017 $1.48M Mar 12, 2020
FY2018 Dec 31, 2016 $1.70M Mar 13, 2019

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $2.71B Mar 13, 2026
FY2025 Dec 31, 2024 $2.78B Mar 13, 2026
FY2024 Dec 31, 2023 $2.71B Mar 14, 2025
FY2023 Dec 31, 2022 $2.65B Mar 13, 2024
FY2022 Dec 31, 2021 $2.42B Mar 22, 2023
FY2021 Dec 31, 2020 $2.28B Mar 23, 2022
FY2020 Dec 31, 2019 $1.79B Mar 24, 2021
FY2020 Dec 31, 2018 $1.76B Mar 24, 2021
FY2019 Dec 31, 2017 $1.71B Mar 12, 2020
FY2018 Dec 31, 2016 $1.66B Mar 13, 2019

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $2.46B Mar 13, 2026
FY2025 Dec 31, 2024 $2.56B Mar 13, 2026
FY2024 Dec 31, 2023 $2.52B Mar 14, 2025
FY2023 Dec 31, 2022 $2.48B Mar 13, 2024
FY2022 Dec 31, 2021 $2.21B Mar 22, 2023
FY2021 Dec 31, 2020 $2.08B Mar 23, 2022
FY2020 Dec 31, 2019 $1.61B Mar 24, 2021
FY2019 Dec 31, 2018 $1.59B Mar 12, 2020
FY2018 Dec 31, 2017 $1.56B Mar 13, 2019
FY2017 Dec 31, 2016 $1.51B Mar 8, 2018

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $254.71M Mar 13, 2026
FY2025 Dec 31, 2024 $215.31M Mar 13, 2026
FY2025 Dec 31, 2023 $195.24M Mar 13, 2026
FY2024 Dec 31, 2022 $166.39M Mar 14, 2025
FY2023 Dec 31, 2021 $211.46M Mar 13, 2024
FY2022 Dec 31, 2020 $199.70M Mar 22, 2023
FY2021 Dec 31, 2019 $182.63M Mar 23, 2022
FY2020 Dec 31, 2018 $165.03M Mar 24, 2021
FY2020 Dec 31, 2017 $149.81M Mar 24, 2021
FY2019 Dec 31, 2016 $143.75M Mar 12, 2020

Goodwill

An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $21.82M Mar 13, 2026
FY2025 Dec 31, 2024 $21.82M Mar 13, 2026
FY2025 Dec 31, 2023 $21.82M Mar 13, 2026
FY2024 Dec 31, 2022 $21.82M Mar 14, 2025
FY2023 Dec 31, 2021 $21.82M Mar 13, 2024
FY2022 Dec 31, 2020 $21.82M Mar 22, 2023
FY2021 Dec 31, 2019 $21.82M Mar 23, 2022
FY2020 Dec 31, 2018 $21.82M Mar 24, 2021
FY2019 Dec 31, 2017 $21.82M Mar 12, 2020
FY2018 Dec 31, 2016 $21.82M Mar 13, 2019

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $256.48M Mar 13, 2026
FY2025 Dec 31, 2024 $247.71M Mar 13, 2026
FY2024 Dec 31, 2023 $229.93M Mar 14, 2025
FY2023 Dec 31, 2022 $211.86M Mar 13, 2024
FY2022 Dec 31, 2021 $188.88M Mar 22, 2023
FY2021 Dec 31, 2020 $168.01M Mar 23, 2022
FY2020 Dec 31, 2019 $153.70M Mar 24, 2021
FY2019 Dec 31, 2018 $143.13M Mar 12, 2020
FY2018 Dec 31, 2017 $128.45M Mar 13, 2019
FY2017 Dec 31, 2016 $124.11M Mar 8, 2018

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $50.10M Mar 13, 2026
FY2025 Dec 31, 2024 $47.04M Mar 13, 2026
FY2024 Dec 31, 2023 $36.85M Mar 14, 2025
FY2023 Dec 31, 2022 $55.87M Mar 13, 2024
FY2022 Dec 31, 2021 $26.98M Mar 22, 2023
FY2021 Dec 31, 2020 $108.54M Mar 23, 2022
FY2020 Dec 31, 2019 $121.90M Mar 24, 2021
FY2019 Dec 31, 2018 $129.97M Mar 12, 2020
FY2018 Dec 31, 2017 $30.73M Mar 13, 2019
FY2018 Dec 31, 2016 $74.16M Mar 13, 2019

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 3 Mar 13, 2026
FY2025 Dec 31, 2024 4 Mar 13, 2026
FY2024 Dec 31, 2023 5 Mar 14, 2025
FY2023 Dec 31, 2022 6 Mar 13, 2024
FY2022 Dec 31, 2021 5 Mar 22, 2023
FY2021 Dec 31, 2020 4 Mar 23, 2022
FY2012 Dec 31, 2012 2 Mar 15, 2013
FY2012 Dec 31, 2011 2 Mar 15, 2013
FY2012 Dec 31, 2010 2 Mar 15, 2013
FY2011 Dec 31, 2009 1 Mar 28, 2012

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 3 Mar 13, 2026
FY2025 Dec 31, 2024 4 Mar 13, 2026
FY2024 Dec 31, 2023 5 Mar 14, 2025
FY2023 Dec 31, 2022 6 Mar 13, 2024
FY2022 Dec 31, 2021 5 Mar 22, 2023
FY2021 Dec 31, 2020 4 Mar 23, 2022

Dividends Paid

Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $6.33M Mar 13, 2026
FY2025 Dec 31, 2024 $7.37M Mar 13, 2026
FY2024 Dec 31, 2023 $5.84M Mar 14, 2025
FY2023 Dec 31, 2022 $5.80M Mar 13, 2024
FY2022 Dec 31, 2021 $5.32M Mar 22, 2023
FY2021 Dec 31, 2020 $5.01M Mar 23, 2022
FY2020 Dec 31, 2019 $5.03M Mar 24, 2021
FY2020 Dec 31, 2018 $4.97M Mar 24, 2021
FY2019 Dec 31, 2017 $4.92M Mar 12, 2020
FY2018 Dec 31, 2016 $4.88M Mar 13, 2019